Abstract Cancer is considered to be an important public health problem throughout the world. Early diagnosis of cancer and recurrent tumors are extremely important for reducing mortality rates and also for following up the response to treatment. The increased need of oxygen leads to new vascular structures in and around the tumor. The most important components of this angiogenic process are vascular endothelial growth factor (VEGF) and its receptors which are overexpressed in tumor cells. The aim of this study is to develop soluble VEGF receptor-1 (sVEGFR-1) functionalized iron oxide nanoparticles for diagnosis of early stages of tumors or metastases by MRI. A single dose of N-nitroso-N-methylurea (NMU) at a concentration of 50 mg/kg was injected to inbred rats intraperitoneally on the 21st day of their birth to create breast cancer. In this study, in vivo characteristics of functionalized nanoparticles were studied by comparing rats with tumors and the healthy controls. Approximately 70 days later, tumor formed rats were administered with nanoparticles functionalized with sVEGFR-1, intravenously and scanned with MRI. MR images were taken before the treatment with nanoparticles (0 minute), and at 30th and 60th minutes after treatment. The evaluation of MRI data revealed that the images of metastases were hypointense at 30th minute with respect to the 0 minute and 60th minute images (p<0.05). Nanoparticles were observed to localize at the tumoral regions and there were significant contrast intensity differences in rats with tumor. These results showed that our sVEGFR-1 functionalized nanoparticles were localized at tumoral regions including metastasis. This method can be useful in diagnosis of early tumors, metastasis, and recurrencies. Further molecular and histological studies are necessary to explain the efficacy of these nanoparticles for tumor diagnosis. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):B153. Citation Format: Taner Ozgurtas, Fatih Yesildal, Fevzi Nuri Aydin, Melis Sardan, Gozde Uzunalli, Murat Kocaoglu, Ayse Begum Tekinay, Mustafa Ozgur Guler, Rukan Genc, Salih Deveci. sVEGFR-1 functionalized nanoparticles for diagnosis of cancer using magnetic resonance imaging. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr B153.